MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'inhaler'. Sat, 03 Sep 2011 02:27:17 +0100 http://www.medworm.com/index.php?rid=4225249&cid=t_93948_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fhelp-for-inhaling-medications%2F2010.12.03 Cambridge Consultants and India’s Sun Pharma Advanced Research Company (SPARC) have developed a new dry powder inhaler. According to the companies, the device delivers an even, consistent drug dose deep into the lungs regardless of how strong the inhalation is performed by the patient. From the press release: The device employs a novel de-agglomeration engine to separate the drug from the lactose ‘carrier’ particles. Based on a highly efficient airway design, the patented drug separation mechanism has successfully completed clinical trials and demonstrated that it is capable of delivering significantly more of the drug to the deep lung than traditional inhalers. In practice, this will minimise side effects from drug build-up in the back of the throat, reduce non-systemic ... Better Health blogs http://www.medworm.com/rss/comments.php?id=4225249 Fri, 03 Dec 2010 17:00:30 +0100 4225249 http://www.medworm.com/index.php?rid=2741320&cid=t_93948_86_f&fid=38272&url=http%3A%2F%2Flaikaspoetnik.wordpress.com%2F2009%2F08%2F28%2Ffriday-foolery-2-how-to-use-your-inhaler-not%2F For the first time seen on Allergynotes: “Compliance” or “Are you using your inhaler right.” I really had to laugh out loud when I saw it, and so did my daughter and husband. Therefore I would like to share it with you. Text with the video: As a doctor half the battle is figuring out if your [...] (Source: Laika's MedLibLog) Laika's MedLibLog blogs http://www.medworm.com/rss/comments.php?id=2741320 Fri, 28 Aug 2009 06:42:59 +0100 2741320 http://www.medworm.com/index.php?rid=2611010&cid=t_93948_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FwH1ZsYdPKOI%2F I’m always a bit leery of surveys that tell me patients aren’t taking their medication. The blame always seems to fall on the patient, rather than doctors who don’t take the time to speak with patients so that they understand what to do to treat their disease. The latest of these studies involves asthma. The study says that two-thirds of physicians treating asthma believe that less than 50% of their patients take their daily asthma controller. My first question when I heard this was, did the doctor properly explain how to use their controller? Did they do it in detail, and talk about why and how it should be administered. I say this because I have asthma and years ago I was handed a new asthma inhaler by a doctor who had no time to discuss anything. Have a question? For... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=2611010 Thu, 16 Jul 2009 22:33:12 +0100 2611010 http://www.medworm.com/index.php?rid=1361152&cid=t_93948_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F267049512%2F The insulin inhaler used to be a joking matter. Not anymore. The drugmaker is updating the labeling after reviewing clinical trial data and post-marketing reports. The actual number of cases was low - six of 4,740 Exubera patients compared with one of 4,292 patients not using the inhaler. One case was also found after Exubera became available. All of the cases, however, involved cigarette smokers, and Pfizer maintains there were too few cases to determine whether these were related to the use of the device. The warning comes just six months after Pfizer abruptly stopped its vain efforts to make a success out of the device, which was widely derided for a cumbersome design that resembled a bong. The failure was perceived as one of the biggest pharma flops in years and the drugmaker was wide... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1361152 Wed, 09 Apr 2008 14:24:09 +0100 1361152 http://www.medworm.com/index.php?rid=1314433&cid=t_93948_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F254336725%2F The drugmaker is also closing a manufacturing facility in Chelsea, Massachusetts, now that Lilly has decided to cancel development of its AIR device, which was in late-stage clinical trials. Earlier this month, Lilly backed out of plans to proceed with the inhaler due to “increasing uncertainties of the regulatory environment” and commercialization concerns, but not safety issues. The move came just a few months after Pfizer ended sales of Exubera. The job cuts amount to 18 percent of Alkermes’ workforce, according to a statement. The drugmaker doesn’t anticipate any expense savings from the restructuring during its current fiscal 2008, which ends March 31, but forecasts savings of about $15 million to $20 million in fiscal 2009. The company expects to record a restruct... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1314433 Wed, 19 Mar 2008 15:14:07 +0100 1314433 http://www.medworm.com/index.php?rid=1294729&cid=t_93948_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F249462697%2F The biotech won’t give up. Despite Lilly’s decision last week to abandon such a product, MannKind pledged to continue developing its insulin inhaler system even though its stock fell in reaction to Lilly’s announcement, The Los Angeles Times reports. But Hakan Edstrom, MannKind’s president, insists the stock, which has lost more than two-thirds of its value in the last year, will bounce back once investors realized its device is superior to the one Lilly had been pursuing. “We’ve been affected by an ongoing flu in the inhaler market, but we’re confident that we’ll come out of this with flying colors,” he tells the Times. “People are looking at all the inhalers as one family without a clear understanding that we have a very differe... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1294729 Tue, 11 Mar 2008 11:58:42 +0100 1294729 http://www.medworm.com/index.php?rid=1204765&cid=t_93948_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F229225924%2F And so Monday is over. Hope yours was as interesting as ours. Now, though, the time has come to catch up on sundry tasks - recycling, for instance, must be carted off the Pharmalot corporate campus this evening - and we hope to indulge later with a good book. See you all in the morning… Schering-Plough Asthma Inhaler Approved For Children (Yahoo/AP) Glaxo Vaccine May Prevent Recurrence Of Lung Cancer After Surgery (The Telegraph) Three Pfizer Employees In Nigerian Court In Trovan Case (Agence France Presse) (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1204765 Tue, 05 Feb 2008 00:29:35 +0100 1204765 http://www.medworm.com/index.php?rid=672213&cid=t_93948_117_f&fid=34444&url=http%3A%2F%2Fblogs.webmd.com%2Fallergies-and-asthma%2F2007%2F06%2Fwhy-one-copd-medication-instead-of.html Why Take a Bronchodilator? Bronchodilator inhalers and pills relax the airways, making them wider so that you can breathe more easily. The goal of bronchodilator therapy is to reduce shortness of breath. If you are not short of breath, or if they don't noticeably relieve your shortness of breath, then perhaps you don't need to take a bronchodilator regularly. Discuss this with your doctor.What Side-Effects are Possible from Bronchodilators? Bronchodilator inhalers and pills are stimulants, like the caffeine in coffee and tea. Thus you may experience nervousness (anxiety), shakiness (tremor), a more rapid pulse, insomnia, or stomach upset (nausea). These will only last for the duration of the effect of the bronchodilator (2 to 4 hours for short-acting inhalers, but 12-24 hours for long-acti... Allergies and Asthma blogs http://www.medworm.com/rss/comments.php?id=672213 Wed, 13 Jun 2007 04:00:00 +0100 672213 http://www.medworm.com/index.php?rid=438174&cid=t_93948_117_f&fid=34444&url=http%3A%2F%2Fblogs.webmd.com%2Fallergies-and-asthma%2F2006%2F01%2Fdeath-by-inhaler.html Should your doctor inform you about the risk of death when prescribing some popular asthma inhalers?The January 2006 issue of the most prestigious allergy journal (JACI) contains articles and editorials regarding the FDA's new "black box" warning for very popular inhalers used by patients with asthma. Serevent (salmeterol), Advair (salmeterol and fluticasone), and Foradil (formoterol). Salmeterol and formoterol are long-acting bronchodilators. The black box quotes data from the "SMART" study of 26,000 adults with asthma randomly given Serevent or placebo for six months (in addition to their usual asthma medications). This "postmarketing surveillance" (phase IV) study was begun ten years ago, and the four times higher asthma-related death rate in the Serevent group (13 deaths versus 3 dea... Allergies and Asthma blogs http://www.medworm.com/rss/comments.php?id=438174 Mon, 09 Jan 2006 05:00:00 +0100 438174